Equities

Acadia Healthcare Company Inc

Acadia Healthcare Company Inc

Actions
  • Price (USD)51.05
  • Today's Change-0.61 / -1.18%
  • Shares traded50.89k
  • 1 Year change+57.32%
  • Beta1.5313
Data delayed at least 15 minutes, as of Jan 26 2021 15:53 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities. The Company is engaged in operating acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers and facilities providing outpatient behavioral healthcare services. Its U.S. Facilities include approximately 224 behavioral healthcare facilities with approximately 9,500 beds in 40 states and Puerto Rico. The Company’s U.K. Facilities include approximately 361 behavioral healthcare facilities with approximately 8,700 beds in the United Kingdom. The Company operates a network of approximately 588 behavioral healthcare facilities with approximately 18,200 beds in 40 states, the United Kingdom and Puerto Rico.

  • Revenue in USD (TTM)3.15bn
  • Net income in USD100.29m
  • Incorporated2005
  • Employees28.40k
  • Location
    Acadia Healthcare Company Inc6100 Tower Cir Ste 1000FRANKLIN 37067-1509United StatesUSA
  • Phone+1 (615) 861-6000
  • Fax+1 (615) 261-9685
  • Websitehttps://www.acadiahealthcare.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Magellan Health Inc5.20bn49.33m2.45bn10.10k48.151.5414.380.4721.975.32206.5561.671.59116.436.41514,379.001.512.202.223.313.623.810.94950.96432.053.100.28890.00-2.1213.75128.02-6.78-0.6287--
BioTelemetry Inc438.83m17.68m2.48bn1.70k149.576.2538.075.650.48320.483212.0011.570.62128.156.79258,134.702.506.712.757.5361.7461.714.038.172.727.320.28540.009.9221.39-30.30--19.16--
Agape ATP Corp3.13m29.66k2.82bn--107,142.90490.165,230.44902.170.000070.000070.00830.01530.5385--6.91--0.5103--0.5644--73.43--0.9477--5.47--0.00--------------
Accolade Inc155.57m-48.07m3.04bn1.24k--7.83--19.56-1.13-1.133.487.040.5801--18.14124,453.60-17.92---24.65--43.43---30.90-----9.560.00--39.76--9.08------
Veracyte Inc112.68m-34.32m3.21bn354.00--7.57--28.46-0.6819-0.68192.217.310.31547.305.46318,296.60-9.61-24.13-10.04-27.6064.1663.71-30.46-33.0126.28-138.730.0018--30.8225.8145.22--6.37--
Burning Rock Biotech Ltd(ADR)59.71m-69.42m3.60bn753.00--9.02--60.25-0.682-0.6820.58673.840.2091.883.8584,701.77-18.69---21.06--69.73---89.40--9.59--0.0177--82.74---43.82------
Option Care Health Inc2.95bn-41.73m3.67bn5.08k--3.6998.511.24-0.2371-0.237116.525.321.1217.188.97580,333.80-1.59-11.52-1.86-14.1222.8626.89-1.42-8.071.200.73010.5412--225.9120.15-20.89--15.39--
Select Medical Holdings Corporation5.45bn206.43m3.85bn35.70k17.953.707.810.70651.591.5941.987.710.7352--6.64152,543.503.863.095.314.1014.8114.295.253.45--3.420.6592.137.3312.227.634.1110.53--
Progyny Inc309.68m3.20m4.16bn167.002,396.4132.64802.6313.430.020.023.381.472.26--5.051,854,365.002.33--4.48--19.75--1.03------0.00--117.92--24.29------
CareDx Inc169.37m-19.98m4.38bn306.00--15.67--25.83-0.4527-0.45273.785.470.67977.206.80553,500.00-8.02-23.24-9.86-33.2966.3859.09-11.79-32.823.98-121.980.00--65.9536.0153.02--35.51--
Acadia Healthcare Company Inc3.15bn100.29m4.60bn28.40k45.641.7416.971.461.131.1335.6529.650.4549--9.21110,797.801.490.83481.620.8946----3.271.691.252.420.54350.003.1525.34161.845.5316.46--
The Ensign Group, Inc.2.08bn132.71m4.65bn24.50k35.936.0725.142.232.392.7337.4914.130.8642--6.9285,090.575.525.156.776.5122.4116.806.383.35--21.070.131916.2216.0714.6654.1220.5928.176.30
Tenet Healthcare Corp17.53bn-13.00m5.28bn88.61k----4.410.3013-0.1297-0.1297166.71-3.550.70778.976.29197,849.001.420.68712.000.955383.1183.832.000.83741.281.450.8871--0.90652.16-325.00---6.41--
NeoGenomics, Inc.425.32m-4.95m6.58bn1.70k--9.48229.1815.48-0.0327-0.03273.896.000.509214.844.37250,187.60-0.5925-0.0738-0.644-0.08341.9445.16-1.16-0.11356.22-1.900.2047--47.7336.2531.5047.8839.64--
1life Healthcare Inc333.23m-100.00m6.84bn1.70k--12.67--20.52-0.8031-0.80312.674.060.457555.467.64196,017.10-13.84---15.78--36.14---30.25--7.35-17.000.3068--29.89---18.32------
Data as of Jan 26 2021. Currency figures normalised to Acadia Healthcare Company Inc's reporting currency: US Dollar USD

Institutional shareholders

62.37%Per cent of shares held by top holders
HolderShares% Held
Wellington Management Co. LLPas of 30 Sep 202011.04m12.41%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Sep 202010.39m11.68%
The Vanguard Group, Inc.as of 30 Sep 20207.38m8.29%
BlackRock Fund Advisorsas of 30 Sep 20206.81m7.66%
Dimensional Fund Advisors LPas of 30 Sep 20206.20m6.97%
P2 Capital Partners LLCas of 10 Dec 20204.31m4.85%
Abrams Bison Investments LLCas of 30 Sep 20202.85m3.20%
JPMorgan Investment Management, Inc.as of 30 Sep 20202.35m2.64%
SSgA Funds Management, Inc.as of 30 Sep 20202.15m2.41%
Davide Leone & Partners Investment Co. Ltd.as of 30 Sep 20202.02m2.27%
More ▼
Data from 30 Sep 2020 - 30 Sep 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.